Introduction and hypothesis Benign joint hypermobility syndrome (BJHS) is a connective tissue disorder associated with joint hypermobility. BJHS is under-recognised by medical professionals and is poorly managed. The aim of our study was to determine whether lower urinary tract symptoms (LUTS), including urinary incontinence (UI) and anterior compartment prolapse, are more common in women with BJHS than in the normal population.
Introduction
Urinary incontinence (UI) is a common condition that significantly impairs quality of life (QoL) [1] . It is defined by the International Continence Society (ICS) and International Urogynaecology Association (IUGA) as the involuntary loss of urine [2] . The prevalence ranges from 12.8 % to 46 % [3] . Definitions of lower urinary tract function and dysfunction have also been standardised as a consensus document between IUGA/ICS [2] . Urinary incontinence is multifactorial and increases with age [4] . Age-related urogenital atrophy with its associated reduction in skin collagen content is assumed to be a causative factor. Inherited, intrinsic genetic abnormalities of collagen synthesis may also contribute to UI. These may range from more severe forms of connective tissue disorders, such as Marfan's syndrome and type IV Ehlers-Danlos syndrome, to benign joint hypermobility syndrome (BJHS), also known as the hypermobile type of Ehlers-Danlos (or Ehlers-Danlos type III) syndrome. The basic pathophysiology of BJHS is due to an underlying abnormality in collagen where the ratio of type III to type I collagen is increased [5] . This means that tissue is more stretchable, which may result in generalised tissue damage. BJHS usually presents with a variety of musculoskeletal problems ranging from joint subluxation to tendosynovitis. It may also affect multiple other systems, including the musculotendinous pelvic floor. This can result in pelvic floor problems in women, such as pelvic organ prolapse (POP) and UI. Given the background abnormality of collagen in BJHS, the aim of this case-control study was to identify whether the prevalence of lower urinary tract symptoms (LUTS), including UI, in the BJHS population is greater than in normal women. The relationship between BJHS, voiding difficulties and prolapse was also explored.
Materials and methods
All patients referred to the tertiary referral hypermobility clinic at University College Hospital with a diagnosis of BJHS were invited to participate in this study between October 2010 and August 2011. University College Hospital has a multinational catchment population and is also one of the three adult hypermobility clinics in the UK. Patients had been sent information leaflets regarding this study with their appointment letters. All control individuals were recruited from King's College Hospital and included general gynaecology patients, medical personnel and other hospital staff. Ethical approval was obtained from the local ethics committee, and all women gave informed consent prior to participation. Inclusion criteria were women aged between 18 and 60 years who understood English. Those who had previous pelvic floor surgery were excluded. All study group participants recruited from University College Hospital were given a diagnosis of BJHS having fulfilled the Brighton criteria [6] . All control participants were screened for BJHS and excluded from participation if they fulfilled the same criteria.
The Brighton criteria ("Appendix 1") comprise sets of major and minor criteria. A diagnosis of BJHS is made when either two major, one major and two minor or four minor criteria were satisfied [7] . The Beighton score ("Appendix 2"), which is one of the major criteria, was once considered the gold standard for recognising hypermobility [6] .
Patients were matched according to age ±2 years, exact parity and ethnicity. The recruitment of controls was performed following the recruitment of cases. All participants were asked to complete the validated King's Health Questionnaire (KHQ) and the Prolapse Quality Of Life (P-QOL) questionnaire. The KHQ is a disease-specific validated QoL questionnaire used in the assessment of women with UI [1]. It evaluates nine QoL domains and nine LUTS-specific areas. The QoL domains include general health perception (GHP), incontinence impact (II), role limitations (RL), physical limitations (PL), social limitations (SL), personal limitations (PL), effect on emotions, effect on sleep and energy and severity. Each domain is given a calculated score out of 100. The higher the score, the more significant the negative impact on QoL. LUTS include frequency, nocturia, urgency, urgency incontinence (UUI), stress incontinence (SUI), nocturnal enuresis, intercourse incontinence, urinary tract infections (UTI) and bladder pain. Each symptom is graded as mild, moderate or severe if present. Questionnaire respondents are given the option of not ticking a box if they feel they do not have a particular symptom listed on the questionnaire. Prevalence is calculated according to whether symptoms are present or not.
The P-QoL is a disease-specific, validated questionnaire developed to assess QoL in women with urogenital prolapse [8] . It focuses on the same nine domains used in the KHQ but in relation to prolapse. It also has a section for urinary-, bowel-and prolapse-specific symptoms related to prolapse. We only included urinary symptoms in relation to voiding dysfunction, such as straining, stream quality, incomplete emptying and postmicturition dribbling. Each symptom is graded according to severity, and their prevalence is calculated according to whether symptoms were present or not, as with the KHQ. Prolapse was measured to examine how it related to voiding difficulties. Objective assessment of prolapse was made with POPstix ® (a wooden measuring spatula with 1-cm intervals) using the International Continence Society (ICS) Pelvic Organ Prolapse Quantification (POP-Q) system [9] . This system is a standardised and descriptive method that allows measurement of the support of nine specific points of the vagina in centimetres. We then compared KHQ scores, voiding dysfunction symptoms from the P-QoL and all nine points of the POP-Q between study patients and controls. The power calculation was based on the prevalence of UI in women with BJHS in a study by Jha et al. [10] . The prevalence of incontinence in this study was 60 % in the BJHS group, and it was calculated that 60 participants in each group would result in a power of 80 % to detect a difference of 30 % at a 5 % significance level.
Statistical methods
All analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, IL., USA)
Results
One hundred and twenty individuals (60 study patients, 60 controls) were recruited during a 10-month period. All patients were matched with healthy volunteers according to age (p = 0.096), parity (p = 0.321) and ethnicity (p = 0.188). The age range was from 18 to 60 (mean 39.4) years. Median parity was 1 (range 0-3). The prevalence of UI, as calculated from the KHQ, in those with BJHS was 73.3 % (44/60) and 48.3 % (29/60) (p=0.009) in controls. Sixty-two per cent (37/60) of the study group had UUI, which was significantly more than the 38.3 % (23/60) in the control group (p=0.017). Although the prevalence of SUI in the study group was 63.3 % (38/60) compared with 36.7 % in the control group, this was not statistically significant (p= 0.141). There was a significant difference between study and control groups in all the other urinary-specific symptoms of the KHQ except for intercourse incontinence (Fig. 1) .
Symptoms of voiding dysfunction are not incorporated in the symptom-specific section of the KHQ. These results were obtained from the P-QoL (Table 1) . It is evident that a significant number of women with BJHS suffer from voiding dysfunction. Most patients in the study group (63.3 %) felt they had incompletely emptied their bladders in comparison with a small number (23.3 %) in the control group. A considerable proportion (48.3 %) of women with BJHS felt they needed to strain in order to empty their bladders. Only 13.3 % of the control group felt they needed to strain in order to empty their bladders. This may have led to the high percentage of women with BJHS suffering from UTI and bladder pain (Fig. 1) .
The impact of UI on QoL between cases and controls was statistically significant in all nine domains of the KHQ (Fig. 2) .
When considering prolapse of the anterior compartment, there was a significant difference in prolapse between groups (Table 2 ). There was also a significant correlation between prolapse in the anterior compartment and incomplete bladder emptying (p=0.037).
Discussion
This is the largest case-control study to our knowledge comparing the prevalence of UI in those with BJHS to a control group. As expected, the prevalence of UI was significantly greater in the hypermobile population. When patients were asked about the severity of incontinence, it was mostly mild on a severity scale. Interestingly, a considerable number of women in the study group also suffered from voiding dysfunction. UI had a considerably negative impact on all aspects of QoL. It is possible that UI has an impact on the mechanical aspects of their BJHS, which affects all domains of QoL, resulting in a significant difference. Women with BJHS have a wide variety of problems in relation to the lower urinary tract and lower bowel. The literature indicates that these patients experience UI and anal incontinence and also obstructed defecation.
The prevalence of incontinence ranges from 42 % to 60 % [10] . This has been confirmed by our study, albeit with a greater prevalence of 73 %. This may be due to our larger cohort. Although the reported incidence of SUI and UUI is similar, only the difference in UUI between study and control groups was statistically significant. A significant portion of women with BJHS felt their LUTS had a negative impact on QoL. This is contrary to the published data from Jha et al. [10] , which showed that despite a statistically significant proportion of women with UUI and anal incontinence, their impact on QoL was minimal. When considering the second domain (incontinence impact on QoL) of the KHQ in relation to those with UI, a significant portion felt that this affected them moderately to severely. Enquiring about and identifying these symptoms can lead to the provision of numerous treatment options that can result in a considerable improvement in QoL.
It has been postulated [11] that women with BJHS have a higher incidence of obstructed defecation due to either pelvic floor weakness or a connective tissue disorder inhibiting appropriate bowel-wall motility. This may also be true with regard to voiding dysfunction, which we have shown to be problematic in the hypermobile cohort. This may again be either due to a connective tissue defect in the pelvic floor, resulting in a cystocele and therefore an anatomical problem, or it may be functional. These could also be due to a defect in the connective tissue in the bladder wall affecting bladder Fig. 2 Comparison of the mean King's Health Questionnaire (KHQ) scores on the y axis between study and control groups. (The maximum score of 100 was not incorporated in the y axis to allow easier data interpretation). All domains were statistically significant; p<0.05 We acknowledge that our study had some weaknesses. Although incontinence was identified by means of questionnaires, this does not always necessarily correlate with the urodynamic diagnosis. The bladder has been described as an "unreliable witness", and urodynamic investigation would be ideal in order to identify types of incontinence [12] . This would be interesting, as theoretically, the pathophysiology underlying UI in those with BJHS is more likely to be due to a weakness in the pelvic floor or intrinsic sphincter deficiency rather than detrusor overactivity. In addition, QoL questions on both the KHQ and P-QoL are validated; the sections on LUTS in relation to incontinence and prolapse provide only a subjective assessment. They would not be considered reliable for objectively assessing the lower urinary tract. Whilst the researcher collecting the data did ask study participants whether they would consider further investigation/therapy for their incontinence, it would have been useful to use a more structured survey questionnaire or patient symptom perception questionnaire to establish the exact proportion.
Conclusion
Incontinence is a source of much embarrassment to women. However, clinicians rarely acknowledge the substantial impact it has on the QoL of women with BJHS, as a large and understandable proportion of time is spent in specialised rheumatology/hypermobility clinics considering all other aspects of this condition. Thus an insignificant amount of time, or sometimes none at all, is spent asking about gynaecological issues. Underdiagnosis of these issues may be in part due to patient underreporting of their symptoms to their physicians and in part to a failure by general practitioners and rheumatologists to routinely screen for these symptoms. It is important to identify women who are symptomatic. The addition of a systematic, active case-finding approach may be more effective in identifying these cases. Such a high prevalence of incontinence may justify the need for an integrated continence pathway in the larger specialised hypermobility units in the country.
